Back
Actinium Pharmaceuticals 10K Form
Sell
26
ATNM
Actinium Pharmaceuticals
Last Price:
6.55
Seasonality Move:
7.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ATNM News And Ratings
See the #1 stock for the next 7 days that we like better than ATNM
ATNM Financial Statistics
Sales & Book Value
| Annual Sales: | $81K |
|---|---|
| Cash Flow: | $-7.49M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.32 |
| Price / Book: | 5.3 |
Profitability
| EPS (TTM): | -1.83000 |
|---|---|
| Net Income (TTM): | $-48.82M |
| Gross Margin: | $0 |
| Return on Equity: | -95.08% |
| Return on Assets: | -50.26% |
Actinium Pharmaceuticals Earnings Forecast
Key Actinium Pharmaceuticals Financial Ratios
- The Selling, General & Administrative Expenses for ATNM have been equal to 16,458.02% of Gross Profit Margin.
- The Research & Development expenses have been 47,740.74% of Revenue.
- The Interest Expense is -0.02% of Operating Income.
- Per Share Earnings over the last 18 years have been positive in 9 years.
Actinium Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ATNM |
| CUSIP: | 00507W |
| Website: | actiniumpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 9.21 |
| Quick Ratio: | 9.03 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ATNM Technical Analysis vs Fundamental Analysis
Sell
26
Actinium Pharmaceuticals (ATNM)
is a Sell
Is Actinium Pharmaceuticals a Buy or a Sell?
-
Actinium Pharmaceuticals stock is rated a Sell
The current Actinium Pharmaceuticals [ATNM] share price is $6.56. The Score for ATNM is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.